# Trade Mark Journal No.2025/024 13 June 2025

## WO0000001855901 (35,42)

Office of origin: United States of America

Date of International Registration:3 April 2025
Date of designation in the UK: 3 April 2025

International priority date claimed: 3 April 2025 (United States of America) (99119827)

Class 35
  Collection and analysis of quality metric data for market research and statistics in the healthcare, pharmaceutical, medical, biotechnology, and life sciences industries for business purposes; business services provided to the healthcare industry, namely, the collection, reporting, and analysis of social media and on-line content for business purposes; compiling and analyzing statistics, data, and other sources of information for business purposes using artificial intelligence (AI); analysis of market research data and statistics; and product and brand evaluation services, namely, the collection and analysis of qualitative and quantitative data for the generation of reports that measure the performance of Digital Opinion Leaders (DOLs), Key Opinion Leaders (KOL), and others, regarding the reach, relevance, resonance, and rhythm as they relate to specific brand goals.
Class 42
  Providing temporary use of on-line and cloud-based, non-downloadable software and applications using artificial intelligence (AI) for enhancing customer engagement and streamlining business operations in the healthcare, pharmaceutical, medical, biotechnology, and life sciences industries, namely, software; providing temporary use of on-line and cloud-based, non-downloadable software and applications using artificial intelligence (AI) for summarizing social listening data aggregated from digital opinion leaders for use in the healthcare, pharmaceutical, medical, biotechnology, and life sciences industries; software as a service (SAAS) services featuring software using artificial intelligence (AI) to provide real-time data summarization and sentiment analysis, enabling strategic engagements with medical experts at conferences, tracking and analyzing global conferences, and providing curated insights to help clients evaluate treatments, trials, and data readouts; software as a service (SAAS) services featuring software using artificial intelligence (AI) to search, identify, summarize, and analyze social media, digital content, and publications by experts, namely, digital opinion leaders, using proprietary methodology to identify impactful digital opinion leaders, and provide clients with valuable insights to amplify their clinical messages.

Precision Medicine Group, LLC

Representative: Donna H. Hartman OlenderFeldman LLP, 422 Morris Avenue, Summit NJ 07901, UNITED STATES OF AMERICA